jCyte, Inc:

A Platform Cell Therapy To Restore Vision

Date & Time

April 4, 4:00 PM ET / 1:00 PM PT
Webinar Details provided upon RSVP Approval

About the Event

jCyte is developing jCell, a first-in-class platform cell therapy that holds the potential to restore vision in the millions of people worldwide with blinding retinal diseases. Recent Phase 2b clinical results in Retinitis Pigmentosa have shown excellent safety and efficacy to date, with many patients having regained years of prior lost vision.

Join our webinar with the jCyte leadership team to learn more about what the company’s FDA RMAT designation, support from CIRM, and other strategic partnerships mean for the path forward. 

Sign Up Today


All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.